/
Want better conversions for your paid ads? Learn more
Book a demo

DTC Supplements Benchmarks 2026 + Free Calculator

May 12, 2026 · Bradley Jones

The short version:

Top DTC Supplements & Health Statistics at a Glance

  1. Overall DTC ecommerce CAC: $68 to $84, up 40 to 60% since 2021 (Swell 2026)
  2. Meta median cost per purchase (vitamins/supplements): $45.62 vs cross-category $30 to $35 (Varos April 2025)
  3. Meta median CPC for vitamins/supplements: $1.46 (Varos April 2025)
  4. Meta median CPM for vitamins/supplements: $17.78 (Varos April 2025)
  5. Meta CTR for vitamins/supplements: 1.01% (Varos April 2025)
  6. Google Ads Health & Fitness CPC: $5.00, CTR 7.2%, CVR 6.8%, CPL $62.80 (PPC Chief 2026)
  7. Google Ads vitamins/supplements median CPM: $15.34, cost per conversion $21.49 (Varos April 2025)
  8. Health & Wellness CPM inflation YoY: +24.73% to $19.69 (steepest of any category) (Triple Whale 2025)
  9. Health & Wellness ROAS: 2.12 (down 15.64% YoY, steepest decline) (Triple Whale 2025)
  10. Meta January 2025 health policy: optimization restricted to Landing Page Views and Engagement (no Purchase/ATC) (Meta Transparency Center / AdAmigo 2025)
  11. Estimated ad efficiency drop from Meta health policy: 30 to 40% (Polar Analytics via Shop2App)
  12. FTC supplement enforcement: 120+ cases in the past decade (FTC.gov)
  13. Lumosity FTC settlement: $2M for false brain-training claims (2016) (FTC)
  14. Legion Media FTC settlement: $27.6M for unauthorized billing (2024 to 2025) (FTC)
  15. AG1 (Athletic Greens) 2024 revenue: ~$600M, valuation $1.2B (grew from $160M in 2021) (Fortune Jan 2025)
  16. Hims & Hers 2024 revenue: $1.5B (+69% YoY), 2.2M subscribers, 79% gross margin, 85% retention (Hims IR Q4 2024)
  17. Ro (Roman) 2024 annualized revenue: $598M (+66% YoY) (Sacra)
  18. Ritual 2024 retail sales: $250M+, 2M+ lifetime customers, ~70% gross margins (Norwest / PATI Group)
  19. Supplement subscription churn: 5 to 8% monthly (replenishment models 7 to 10%) (Eightx 2026)
  20. DTC retention average: 28%; top performers 35%+ (Swell 2026)
  21. Supplement/vitamin LTV: $300 to $600 driven by subscription (Recharge)
  22. Email open rate Health & Beauty: 37.8% (top performers ~55%) (Klaviyo 2024)
  23. TikTok CPC: 40 to 50% cheaper than Facebook; CVR 1.92% average ecomm (Triple Whale / Lebesgue 2026)
  24. Meta automated systems flag 90%+ of violative health ads in under 2 minutes (AdAmigo 2025)
  25. FTC January 2023 guidance: "competent and reliable scientific evidence" required for health claims, replacing the Dietary Supplements Advertising Guide (Covington analysis)
  26. Global DTC supplement market projected: $45B+ by 2026 (Pharmoniq 2026)
  27. Personal care and supplements site CVR benchmark: 6.8% vs Shopify avg 1.4 to 1.8% (Champion Bio 2025)
  28. Vitamin business valuation multiples: 0.5x to 2.0x TTM revenue; pure ecom operators 1.5x to 2.0x (DealStream)
  29. FDA New Dietary Ingredient (NDI) Notification: 75 days before launch required, with safety evidence and manufacturing documentation (Matsun Nutrition)
  30. cGMP (Current Good Manufacturing Practices) and third-party testing required for supplement manufacturing; voluntary clinical trials becoming category differentiator (Clarkston Consulting 2026)

Compliance Cost Calculator coming soon. A widget will live here that takes your sub-category, headline CPL/CPP, platform, monthly subscription price, subscription conversion rate, and monthly churn, then returns estimated true CPL after compliance friction tax, compliance tax percentage, 12-month subscriber LTV, LTV:CAC ratio, and a verdict tier. For now, use the formula below: True CPL = Headline CPL × (1 + Compliance Friction Tax), with the friction tax typically running 20 to 60% across platforms.

DTC supplement brands pay a structural premium on every acquired lead, and most don't quantify it correctly. The supplement category sits inside four overlapping regulatory layers: the FTC governs marketing claims, the FDA oversees labeling and disease assertions, Google restricts what health products can be advertised under what conditions, and Meta (as of January 2025) blocks lower-funnel optimization for health advertisers entirely. The combined effect is a 20 to 60% premium on cost per lead compared to unregulated DTC categories. Varos's April 2025 vitamins and supplements benchmark report puts Meta median cost per purchase at $45.62, compared to $30 to $35 for general DTC categories. Triple Whale's 2025 analysis shows Health & Wellness CPMs inflated 24.73% year-over-year to $19.69, the steepest increase of any category. This article assembles every major DTC supplement benchmark into one reference and introduces the Compliance-Constrained Acquisition Model that quantifies the regulatory friction tax operating across paid acquisition.

Why Supplements Have a Regulatory Friction Tax

Supplement brands operate inside four overlapping regulatory layers that no other DTC category faces simultaneously.

The FTC restricts marketing claims. The FTC requires "competent and reliable scientific evidence" for any health claim in supplement advertising. The January 2023 FTC guidance replaced the older Dietary Supplements Advertising Guide and set a higher evidence bar: randomized controlled trials are typically required for stronger claims; observational studies and anecdotal evidence are usually insufficient. Brands making structure or function claims (supports joint health, promotes restful sleep) can do so with a DSHEA disclaimer. Disease claims (treats arthritis, prevents Alzheimer's) require FDA drug approval and are otherwise banned. Comparative claims (more effective than competitor) require head-to-head clinical evidence. The FTC has filed 120+ enforcement cases against supplement brands in the past decade.

The FDA governs labeling and disease assertions. FDA labeling rules require ingredient disclosure, supplement facts panels with specific formatting, and warnings for certain ingredients. The FDA's interpretation of what qualifies as a "disease claim" is broader than most marketers assume: words like "treat," "cure," "prevent," and "manage" all trigger drug classification. Supplements positioned to treat anxiety, depression, ADHD, or any clinical condition face FDA enforcement risk even when the brand markets them through indirect language.

Google restricts health-vertical advertising. Google Ads health policy allows general vitamins and supplements with appropriate disclaimers. Prescription products require LegitScript certification. Some categories are fully banned: ephedra, hCG for weight loss, certain hormone products. The restrictions vary by country and update regularly. Brands operating in multiple regions face compounding compliance complexity. PPC Chief 2026 data puts Google Health & Fitness CPC at $5.00, well above the $2 to $3 cross-industry average.

Meta restricted health-vertical optimization in January 2025. This is the most consequential recent regulatory development for supplement DTC. Meta's January 2025 health policy update blocked health advertisers from optimizing campaigns for lower-funnel events like Purchase and Add to Cart. Health-vertical advertisers must now optimize for upper-funnel events: Landing Page Views and Engagement. Polar Analytics via Shop2App estimates the change reduced ad efficiency for health brands by 30 to 40%. Meta's automated systems flag 90%+ of violative health ads in under two minutes, accelerating creative rejection cycles and forcing supplement brands to produce 2 to 3x more ad variants than equivalent unregulated DTC brands.

The four layers compound. A supplement brand that crafts an FTC-compliant claim, navigates FDA labeling rules, applies Google's health-vertical disclaimers, and works around Meta's optimization restrictions is still paying more per lead than a fashion or pet brand running the same playbook in their respective categories. The premium isn't a creative or targeting failure. It's a structural cost embedded in the channel itself.

The Compliance-Constrained Acquisition Model

This is the section nobody else publishes. True CPL equals headline CPL plus the compliance friction tax.

The model:

True CPL = Headline CPL × (1 + Compliance Friction Tax)
Where Compliance Friction Tax = sum of:
  + CPM inflation premium (Health & Wellness +24.73% vs cross-industry)
  + Optimization restriction penalty (Meta: no Purchase/ATC optimization)
  + Creative rejection overhead (2 to 3x more ad variants needed)
  + Legal review cost per ad (compliance team or outside counsel)
  + ROAS decline from restricted targeting (-15.64% in 2025)

Worked example: vitamin brand running Meta ads in 2026.

Component Unregulated DTC Supplement DTC Tax
Median Meta CPM $14.00 cross-industry $17.78 vitamins (Varos) +27%
Optimization events Purchase, ATC, Checkout Landing Page Views, Engagement only -30 to 40% efficiency
Creative variants needed 3 to 5 per cycle 8 to 15 per cycle (rejections + review) +2 to 3x production cost
Median cost per purchase $30 to $35 cross-category $45.62 (Varos) +30 to 52%
ROAS trend Category-dependent 2.12 H&W (down 15.64% YoY) Declining faster

A supplement brand running the same Meta acquisition playbook as a comparable fashion or pet brand pays $45.62 per purchase versus the $30 to $35 typical cross-category. Before accounting for creative production overhead and legal review, the supplement brand is at a 30 to 52% structural cost disadvantage. Layer in the additional compliance overhead and the true effective CAC premium can exceed 60% for brands navigating multiple regulatory layers simultaneously.

The friction tax shows up in different forms across platforms. Google CPC of $5.00 for Health & Fitness represents a 69% premium over the $2.96 cross-industry average. TikTok runs 40 to 50% cheaper than Meta on raw CPC but enforces health claim restrictions that limit creative options. Email and SMS face fewer regulatory restrictions for already-consented audiences but require careful claim management even in owned channels.

The calculator above runs the Compliance-Constrained Acquisition Model on your specific numbers. Enter your headline CPL by platform, your sub-category, and your subscription mechanics, and it returns true CPL, the compliance tax percentage, and a verdict on whether your unit economics work after applying the regulatory premium.

Supplement Economics by Sub-Category

The supplement category aggregate hides materially different economics across sub-verticals. The brands that succeed structure their economics around their specific sub-category's CAC, AOV, and subscription mechanics.

The broader market context: Pharmoniq's 2026 supplement industry analysis projects global DTC supplement revenue at $45B+ by 2026, with personal care and supplements site CVR benchmarks at 6.8% per Champion Bio 2025 (well above the 1.4 to 1.8% average Shopify store CVR). The valuation context matters for brands building toward exit: DealStream's vitamin manufacturing benchmarks put trailing-twelve-month revenue multiples at 0.5x to 2.0x, with pure-ecommerce DTC operators leveraging social media advertising typically achieving 1.5x to 2.0x.

Vitamins and multivitamins (Ritual-style) anchor the category. CAC runs $45 to $80 according to triangulated industry estimates and DTC benchmark sources. Subscription rate sits at 40 to 70% for brands that default to subscription at checkout. Monthly churn averages 5 to 8% per Eightx 2026. AOV runs $30 to $65 monthly with 12-month LTV in the $300 to $600 range per Recharge benchmarks. Ritual is the category benchmark: PATI Group / Norwest analysis shows $250M+ in 2024 retail sales across channels, 2M+ lifetime customers, and approximately 70% gross margins. The vitamins category benefits from broad cultural adoption (most Americans consider vitamins normal) and Google Ads access (vitamins are allowed with disclaimers).

Performance greens (AG1-style premium products) operate at the top of supplement CAC. Estimated CAC $100 to $200+ reflects the premium positioning and aggressive acquisition spend characteristic of single-SKU subscription models. Fortune's January 2025 coverage of Athletic Greens (AG1) puts AG1 revenue at approximately $600M in 2024 with a $1.2B valuation, growing from $160M in 2021. Subscription conversion is very high because the product is sold almost exclusively as a $79 to $99 monthly subscription. Lower-than-average churn reflects the premium product positioning and the customer commitment that comes with a single-SKU subscription. LTV estimates run $600 to $1,200 over 12 months for retained subscribers.

Nootropics (Magic Mind-style) face higher CAC and category novelty. Estimated CAC $80 to $150. Subscription conversion is moderate because the category is newer and customers haven't established replenishment habits. Churn runs higher than vitamins because customers test the product rather than committing to long-term routines. AOV $55 to $100 monthly. LTV estimates $200 to $500. The category's growth is driven by influencer content and biohacker positioning, but the regulatory layer is meaningful: FTC scrutiny of cognitive enhancement claims is active.

Sleep and wellness (Olly-style) operate as more impulse-driven than subscription-first. Estimated CAC $40 to $70, supported by retail distribution as much as DTC. Olly is heavily retail-driven (Target, Whole Foods, Amazon) with DTC playing a discovery role rather than primary revenue. Subscription rate is moderate; AOV $25 to $45; LTV $80 to $200 for DTC-only customers, materially higher when accounting for retail repeat purchases. The category benefits from gummy formats and approachable branding that lowers the trial barrier.

Hydration (Liquid IV-style) operates as a retail-first category with DTC playing acquisition. CAC estimated $35 to $60, largely because the category benefits from impulse purchasing at retail price points. Subscription is low and not the dominant model. Liquid IV's growth was driven by retail expansion and acquisition by Unilever rather than DTC subscription economics. The category demonstrates that not every supplement sub-vertical needs to chase subscription LTV; some categories work better as retail-first with light DTC.

Hormone health and telehealth (Hims, Hers, Ro) operate at the highest revenue tier in supplement DTC. Hims & Hers Q4 2024 IR data discloses $1.5B in 2024 revenue (+69% YoY), 2.2M subscribers, 79% gross margin, and 85% retention. CAC ranges from $89 (blended new customer) to $929 (fully-loaded subscriber acquisition per Kroker Equity Research); the discrepancy reflects different methodologies, with both numbers defensible depending on whether you include sales and marketing operations beyond ad spend. Ro produced $598M in annualized 2024 revenue (+66% YoY). The model works because telehealth-supplement hybrids bundle prescription products (often dispensed through partner pharmacies) with supplement upsells in a single subscription. The prescription anchor produces retention and gross margin that pure supplement DTC can't match.

Women's health and prenatal (Ritual, Perelel) follow vitamin economics with sub-category specialization. CAC $50 to $90. Subscription conversion high. Monthly churn low-moderate. AOV $30 to $40. LTV $300 to $500. The category benefits from life-stage commitment (prenatal vitamins, menopause support) that creates natural subscription lifecycle.

The bottom line for any supplement brand evaluating CAC: don't benchmark against the supplement category average. Benchmark against your sub-category, factor in your AOV and subscription mechanics, and apply the compliance friction tax to project true acquisition economics.

The FTC and FDA Layer

The regulatory environment for supplement DTC has tightened materially in 2023 to 2025, and the cost of non-compliance has risen.

FTC enforcement structure. The FTC's January 2023 guidance replaced the older Dietary Supplements Advertising Guide and tightened the evidence standard. Brands making claims must hold "competent and reliable scientific evidence." For most product claims, this means randomized controlled trials. Observational studies, mechanism-of-action evidence, and traditional use historical evidence are typically insufficient. The new standard applies retroactively to existing marketing creative, which means brands operating with claims from 2020 to 2022 may now face elevated risk.

Notable FTC enforcement actions provide the precedent. Lumosity (Lumos Labs) settled for $2 million in 2016 over deceptive brain-training claims. Legion Media reached a $27.6 million settlement in 2024 to 2025 for unauthorized billing schemes related to supplement subscriptions. TruHeight, Sobrenix, and others have settled for amounts ranging from $300K to $50M+. The FTC publishes settlement details on its health enforcement page, which functions as a precedent database for brands evaluating risk.

Permitted vs prohibited claim structures. Structure or function claims with DSHEA disclaimers are permitted: "supports immune health," "promotes restful sleep," "helps maintain cognitive function." Disease claims without FDA drug approval are prohibited: "treats anxiety," "cures insomnia," "prevents Alzheimer's." The line between the two is narrower than most marketers assume. "Helps reduce occasional sleeplessness" can be a structure/function claim; "helps treat chronic insomnia" is a disease claim. The FTC and FDA interpret the line strictly.

Influencer compliance is now enforced. Influencer health claims share liability between the brand, the agency, and the creator. The FTC has clarified that all parties in the marketing chain are responsible for substantiation, not just the brand. Brands working with influencers in supplement and health categories need contractual indemnification, claim review processes, and substantiation documentation. The cost of getting this wrong has risen as the FTC has signaled more aggressive enforcement against influencer health misinformation.

FDA New Dietary Ingredient (NDI) requirements add product-launch friction. New ingredients (those marketed in the US after October 1994) require an NDI notification filed with the FDA at least 75 days before market launch. The filing must include evidence of safety, specific product manufacturing details, and intended-use disclosure per Matsun Nutrition's regulatory guide. Brands launching novel ingredients face longer product-launch cycles than brands sticking with established ingredients, which shapes both product strategy and acquisition timing.

cGMP compliance is mandatory. Current Good Manufacturing Practices apply to all supplement manufacturing. Brands not operating under cGMP-compliant manufacturing partners face FDA enforcement risk and potential consumer protection litigation. Clarkston Consulting's 2026 supplements trend analysis finds leading DTC supplement brands are voluntarily exceeding regulatory requirements, conducting clinical trials, and publishing third-party testing data to build scientific credibility that justifies premium pricing.

State attorney general enforcement adds another layer. California, New York, and Texas state AGs have brought supplement-related enforcement actions independent of FTC activity. Brands operating in multiple states face state-level enforcement risk in addition to federal regulatory exposure.

The practical cost of compliance. Established supplement DTC brands typically budget for outside legal counsel review of all paid creative ($500 to $2,500 per ad concept depending on complexity), substantiation documentation for all health claims (internal or contracted with regulatory affairs firms), and quarterly review of marketing assets against current regulatory guidance. The compliance overhead is real and adds to the friction tax on supplement DTC economics.

Platform Compliance: Google Health Vertical and Meta Health Policy

Beyond FTC and FDA regulation, the major paid platforms enforce their own health-vertical policies that further constrain supplement DTC acquisition.

Google Ads health policy is category-by-category. Vitamins and multivitamins are allowed with appropriate disclaimers. Prescription products require LegitScript certification through a vetting process that takes 30 to 90 days and costs $1,000 to $5,000+ per product. Some categories are fully banned: ephedra, hCG for weight loss, certain hormone products. Restricted categories vary by country: products legal to advertise in the US may be banned in the EU or vice versa. Google updates its health vertical policies regularly, and category-level enforcement changes catch many brands off guard.

Meta health policy changed dramatically in January 2025. Health advertisers can no longer optimize for Purchase, Add to Cart, or Checkout events. Health brands must now optimize for upper-funnel events: Landing Page Views and Engagement. The change is structural, not creative-driven. Even fully compliant brands with strong creative pay a 30 to 40% efficiency tax because the optimization signal is upstream of the conversion event the brand actually cares about. Polar Analytics estimates this single policy change accounts for the largest share of the supplement-DTC efficiency drop observed in 2025.

Meta automated rejection accelerates. AdAmigo 2025 analysis finds Meta's automated systems flag 90%+ of violative health ads in under two minutes. The rapid rejection cycles mean supplement brands cycle through 8 to 15 ad variants for every 3 to 5 variants an unregulated DTC brand needs. Production overhead, creative review time, and appeals processes all compound to slow campaign iteration.

Common Meta rejection triggers for supplement ads: before-and-after photos (almost universally rejected), close-up body part images (often rejected as suggestive), symptom-based language ("are you tired of feeling exhausted?"), specific health outcome claims ("lose 10 pounds in 30 days"), implication of medical efficacy without disclaimers. Brands that systematically avoid these triggers reduce rejection rates but lose creative flexibility that helps acquisition cost in other categories.

TikTok enforces less aggressively than Meta but has its own restrictions. TikTok prohibits paid promotion of certain supplements (some weight loss, sexual health, hormone products) and requires disclaimers for others. Enforcement is less automated than Meta, which means more ads pass review initially but the platform reserves the right to remove ads or campaigns retroactively. Brands relying on TikTok for supplement acquisition should treat policy compliance as a strategic moat rather than an afterthought.

The practical implication for budget allocation. Brands in restricted sub-categories (hormone health, certain nootropics, weight management) face Google access constraints and may need to lean more heavily on Meta or alternative channels. Brands in allowed sub-categories (general vitamins, broadly compliant supplements) can run Google more aggressively. The platform decision is part regulatory positioning, part competitive dynamics.

Telehealth-Supplement Hybrid Economics

The fastest-growing DTC health businesses in 2024 to 2025 blur the line between prescription telehealth and supplement subscription, producing economics neither pure category can match.

Hims & Hers Health is the category benchmark at scale. Hims Q4 2024 financial results disclose $1.5B in 2024 revenue (+69% year-over-year), 2.2 million subscribers, 79% gross margin, and 85% retention. The blended business covers dermatology, mental health, hair loss, sexual health, weight management, and supplemental wellness products. The structural insight: customers acquire the brand for a prescription product (often a generic compounded medication with high gross margin) and stay for the bundled supplement experience. The bundled subscription produces higher AOV, higher gross margin, and lower churn than pure supplement subscription.

Ro (Roman) operates a similar model at slightly smaller scale. Sacra puts Ro's 2024 annualized revenue at $598M (+66% YoY). Ro spans men's health, women's health, weight management, mental health, and supplemental products. The growth trajectory parallels Hims with similar economics: prescription anchoring, supplement upsells, high gross margin, high retention.

LifeMD reports 94% retention as a benchmark, illustrating how telehealth-supplement subscription retention exceeds pure supplement DTC. The mechanism is the prescription anchor: customers who would cancel a supplement subscription don't cancel when canceling means losing a medication they value (or that requires a doctor visit to replace).

The CAC discrepancy in telehealth-supplement is methodological. Different analyses report Hims CAC anywhere from $89 (blended new customer cost across paid channels) to $929 (fully-loaded subscriber acquisition cost including sales operations, telehealth visit costs, prescriber fees per Kroker Equity Research). Both numbers are defensible. The $89 figure reflects ad-spend efficiency; the $929 figure reflects total cost-per-paying-subscriber including the infrastructure to deliver the prescription product. For benchmarking purposes, brands should know which methodology they're applying and ensure cross-brand comparisons use the same definition.

The model has structural barriers to entry. Operating telehealth-supplement hybrids requires LegitScript certification, state-level medical licensing for telehealth providers, partnership with compound pharmacies or 503B facilities, and regulatory infrastructure for HIPAA compliance and prescription dispensing. The cost and complexity create a moat that pure supplement DTC brands can't easily replicate. Brands considering expansion from pure supplement into telehealth-supplement need to budget significantly for the operational infrastructure.

The implication for the broader supplement category is that the highest-LTV DTC health businesses are increasingly the ones that blur with prescription healthcare. Pure supplement DTC remains viable, but the most aggressive growth and retention metrics belong to brands that have crossed the prescription line. The healthcare marketing benchmarks by specialty post provides adjacent context for how the prescription-side economics work.

Subscription Mechanics and Retention

Subscription is not optional for DTC supplement profitability. The single-purchase economics don't work at supplement price points and compliance overhead.

Subscription conversion rates run 40 to 70% for established supplement brands. Brands defaulting to subscription at checkout see the high end of the range. Brands offering subscription as one option among others see the low end. The choice architecture matters more than the discount percentage. AG1's 95%+ subscription rate reflects the product being sold almost exclusively as subscription; Olly's lower subscription rate reflects retail-friendly positioning where subscription is one channel among many.

Monthly churn for replenishable supplements averages 5 to 8%. Eightx 2026 subscription churn data puts vitamins and supplements in the same range as coffee subscriptions (4 to 7%) and well below meal kits (12 to 18%). First-month churn typically runs 20 to 30% as customers test the product, with retained customers stabilizing in months 2 to 12. The first-month testing window is where most subscription churn happens; the brands that retain past month one typically retain to month 12 and beyond.

The Foundry positioning is narrow here. Supplement brands need 2 to 3x more ad variants to navigate Meta's automated rejection, which means more landing page variants are needed to match. Adaptive Marketing platforms that match landing page messaging to specific compliant ad variants reduce the creative-to-landing-page mismatch that drives up cost per purchase. Adaptive Marketing handles the post-click matching layer; the compliance review and platform policy navigation require legal expertise rather than CRO tooling.

Retention beyond month one depends on product-experience fit. Supplements that produce visible effects (energy, sleep quality, skin appearance) retain at the high end of the range. Supplements with subtle or hard-to-attribute effects (multivitamins, general wellness products) retain at the low end. The brands that succeed in low-effect categories invest heavily in customer education, content marketing, and ritual reinforcement to anchor the subscription habit beyond product performance alone.

Subscription LTV math by sub-category. A vitamin subscription at $45 monthly AOV and 6% monthly churn produces a median subscriber lifetime of 16 to 17 months and 12-month subscriber LTV of approximately $540 (revenue, before COGS). At 70% gross margin, that's $378 in 12-month contribution. Against a $60 CAC (including compliance friction tax), the LTV:CAC ratio is approximately 6:1, well above the 3:1 minimum DTC benchmark. The math works, but the same brand operating at a $90 CAC (after applying full compliance tax) produces 4:1, still viable but materially tighter.

Payment recovery infrastructure matters more in supplements than in other categories. Failed payment churn typically runs 25 to 40% of total subscription churn. Brands with intelligent payment retry logic, card-updater services, and dunning email sequences recover 5 to 15 points of churn that would otherwise be permanent. The infrastructure cost is modest; the retention impact is material.

Common DTC Supplement Mistakes

Ten DTC supplement mistakes recur in benchmark audits. Each maps to a structural problem in the Compliance-Constrained Acquisition Model.

1. Running unreviewed health claims in ads. The single most expensive mistake. FTC enforcement actions average $1M to $30M in settlements, and platform policy violations cause account suspensions that interrupt acquisition for weeks. Fix: route every health claim through outside legal counsel before publishing.

2. Ignoring Meta's January 2025 lower-funnel optimization restrictions. Brands still running Purchase or ATC optimization on Meta health accounts are seeing account warnings or restricted ad delivery. Fix: rebuild Meta campaign structure around Landing Page Views and Engagement optimization, with retention conversion tracked through email and subscription platforms rather than pixel-attributed ad events.

3. Treating compliance as a legal problem instead of an acquisition cost. Brands that budget compliance as overhead miss that it's actually a permanent friction tax on every acquired lead. Fix: build the compliance friction tax into channel ROI calculations and CAC targets, not just into legal budget.

4. Not separating brand vs non-brand ROAS. Branded keyword search is the cheapest CAC channel in supplements once awareness exists. Non-brand search faces full health-vertical CPC inflation. Brands blending the two in reporting can't see where the unit economics actually work. Fix: report brand and non-brand ROAS separately and budget accordingly.

5. Scaling spend before subscription conversion justifies it. A supplement brand with 25% subscription conversion can't profitably scale to $100K+ monthly ad spend because the unit economics don't support it. Fix: hold spend flat until subscription conversion exceeds 35 to 40%, then scale.

6. Underestimating the impact of platform creative rejection cycles. Brands producing the same volume of creative as their unregulated DTC competitors will run out of working ads quickly because more variants get rejected. Fix: budget for 2 to 3x the creative production volume of comparable unregulated DTC brands.

7. Defaulting to influencer marketing without compliance infrastructure. Influencer health claims share liability between brand, agency, and creator. Brands without a structured claim review process for influencer content carry elevated FTC enforcement risk. Fix: build a claim-review workflow for all influencer creative before publication, with substantiation documentation for any health assertion.

8. Ignoring telehealth bundling as a strategic option. Pure supplement DTC brands looking at Hims and Ro economics without considering the prescription anchor are comparing different business models. Fix: evaluate whether prescription bundling fits the brand's audience and capital base; the prescription anchor produces materially higher retention and gross margin where it works.

9. Misallocating budget to macro influencers when micro outperforms. Supplement category has a particularly dense micro-creator ecosystem (fitness, wellness, biohacker, parenting). Macro influencer CPA is typically 2 to 3x micro CPA without the retention advantages that justify the premium. Fix: rebalance toward micro and mid-tier creator partnerships with strong substantiation infrastructure.

10. Treating email and SMS as secondary channels. Email and SMS face fewer platform restrictions than paid ads and reach already-consented audiences. Brands underinvesting in owned channels miss the most efficient retention and re-engagement mechanism available to supplement brands. Fix: allocate dedicated headcount or agency budget for lifecycle email and SMS, with separate flows for trial, retention, and win-back.

Audit Your DTC Supplement Economics This Week

The action plan takes 30 minutes and produces clarity on whether your unit economics actually work after applying the compliance friction tax.

Calculate your true CAC after compliance tax. Take your headline CAC and apply the 30 to 50% premium that reflects the compliance friction tax for your platform mix. If LTV:CAC is below 3:1 against true CAC, your channel mix needs work.

Audit your ad rejection rate on Meta. If you're getting more than 30% of new ads flagged or rejected, your creative process needs more compliance review upstream of publication. Track rejection rate by ad concept and adjust the creative brief accordingly.

Check your Meta campaign optimization events. If you're still optimizing for Purchase or ATC on health-vertical campaigns, you're likely getting throttled delivery. Rebuild campaigns around Landing Page Views and Engagement.

Map your subscription conversion rate by acquisition channel. Different channels deliver materially different subscription conversion rates. Brand search converts highest; cold paid traffic typically lowest. Allocate acquisition budget toward channels that produce subscribers, not just single-purchase customers.

Verify your FTC compliance documentation. For every health claim in your live creative, can you produce the supporting evidence in two weeks if the FTC requests it? If not, the unsubstantiated claims are enforcement risk.

Audit your subscription churn by cohort. First-month churn at 20 to 30% is normal. If retained-customer monthly churn exceeds 8 to 10%, your product-experience fit needs work. Survey churned customers to identify whether they're churning on product, price, or perceived value.

Test telehealth bundling if your product category fits. Brands in adjacent prescription categories (hormone health, mental health, weight management, dermatology) should evaluate whether telehealth bundling adds retention math that supports higher CAC. The infrastructure investment is meaningful but the retention advantage is structural.

Pair this audit with the parent ecommerce marketing benchmarks, CAC benchmarks, and healthcare marketing benchmarks by specialty for adjacent context. Cross-reference DTC Beauty benchmarks for replenishable economics, DTC Food & Beverage benchmarks for subscription mechanics, and DTC Pet benchmarks for the parallel regulatory layer (AAFCO and FDA pet food rules mirror the FDA/FTC supplement layer).

Frequently Asked Questions

What is a good CAC for a supplement brand?

DTC supplement CAC varies dramatically by sub-category. Vitamins and multivitamins run $45 to $80. Performance greens (AG1-style premium products) run $100 to $200+. Nootropics run $80 to $150. Sleep and wellness brands (Olly-style) run $40 to $70. Hormone health and telehealth-supplement hybrids (Hims, Hers, Ro) range from $89 blended to $929 fully-loaded. The honest answer is supplement CAC sits 20 to 60% higher than equivalent unregulated DTC categories because of platform restrictions and compliance costs. Target LTV:CAC of 3:1 or better after applying the compliance friction tax.

How do FTC supplement claims rules work?

The FTC requires competent and reliable scientific evidence for any health claim made in supplement advertising, per January 2023 guidance that replaced the Dietary Supplements Advertising Guide. Structure or function claims (supports immunity, promotes healthy sleep) are permitted with a DSHEA disclaimer. Disease claims (treats arthritis, prevents COVID) are banned without FDA drug approval. Comparative claims require head-to-head clinical evidence. Influencer endorsements share liability between the brand, the agency, and the creator. The FTC has filed 120+ cases against supplement brands in the past decade. Recent settlements include Lumosity at $2 million and Legion Media at $27.6 million.

What changed with Meta's health advertising policy in January 2025?

In January 2025, Meta restricted health advertisers from optimizing for lower-funnel events like Purchase and Add to Cart. Health-vertical advertisers must now optimize for upper-funnel events: Landing Page Views and Engagement. The change reduced ad efficiency for health brands by an estimated 30 to 40% according to Polar Analytics. Meta's automated systems flag 90%+ of violative health ads in under two minutes, accelerating creative rejection cycles. The policy applies to vitamins, supplements, weight management, sexual health, sleep, hormone health, and adjacent categories. The structural impact: supplement brands face higher CPMs, more rejected ads, and worse optimization signal than competitors in unregulated DTC categories.

What is the subscription churn rate for supplement brands?

Supplement subscription churn averages 5 to 8% monthly for replenishable categories like vitamins and multivitamins per Eightx 2026, sitting between coffee subscription churn (4 to 7%) and meal kit churn (12 to 18%). First-month churn runs 20 to 30% for most supplement subscriptions as customers test the product. Premium subscription models like AG1 and Hims/Hers report lower retained churn (Hims reports 85% retention) due to product differentiation and bundling. The structural pattern: supplement churn is manageable for replenishable products at moderate price points, but rises quickly for novel categories where customers haven't established replenishment habits.

Can I advertise supplements on Google Ads?

Yes, with restrictions. Google Ads allows general vitamins and supplements with appropriate disclaimers per the health vertical policy. Prescription products require LegitScript certification. Some categories are fully banned: ephedra, hCG for weight loss, certain hormone products. Health & Fitness CPC averages $5.00, well above the $2 to $3 cross-industry average. CTR runs 7.2% and CVR 6.8% per PPC Chief 2026, producing CPL around $62.80. Supplement-specific Google CPM hit $19.69 in 2025 with 24.73% YoY inflation per Triple Whale, the steepest increase of any category. Brands need to monitor Google's health vertical policy regularly because category-level enforcement changes.

How do telehealth-supplement brands like Hims and Ro economics compare?

Telehealth-supplement hybrids operate at different economics than pure supplement DTC. Hims & Hers generated $1.5B in 2024 (+69% year-over-year) with 2.2M subscribers, 79% gross margin, and 85% retention according to Q4 2024 IR data. Ro produced $598M in annualized revenue, up 66% YoY per Sacra. The model blurs prescription and supplement economics: customers subscribe for a prescription product, then accept supplement upsells as bundled add-ons. The bundled subscription drives higher AOV, higher gross margin, and lower churn than pure supplement subscription. LifeMD reports 94% retention as a category benchmark. The trade-off is regulatory complexity: telehealth requires LegitScript certification, state-level medical licensing, and pharmacy partnership infrastructure.

What is the LTV for a DTC supplement subscription?

Vitamin and multivitamin subscription LTV runs $300 to $600 over 12 months per Recharge benchmarks, driven by monthly subscription at $30 to $65 AOV and 5 to 8% monthly churn. Performance greens (AG1-style) reach $600 to $1,200 due to $79 to $99 monthly AOV and lower churn from premium product positioning. Telehealth-supplement hybrids (Hims/Hers, Ro) generate materially higher LTV through prescription bundling: Hims discloses LTV/CAC ratio of 4:1 with average subscriber economics well above pure supplement DTC. The compliance friction tax shifts the LTV calculation: a subscription LTV of $400 against a true CAC of $80 (after the 30 to 50% compliance premium) still produces 5:1 LTV:CAC, but the math is tighter than headline numbers suggest.